Shared user credentials during laboratory walkthrough – 483 risk assessment


Published on 30/01/2026

Risk Assessment for Shared User Credentials During Laboratory Walkthroughs

In the pharmaceutical manufacturing sector, maintaining robust data integrity is critical to compliance with Good Distribution Practices (GDP) and the tenets of ALCOA+. One area of perennial concern arises from the shared use of user credentials during laboratory walkthroughs. Such practices can lead to diminished accountability, heightened risk of unauthorized access, and ultimately place any facility at risk of regulatory scrutiny, including FDA 483 observations.

For a broader overview and preventive tips, explore our Data Integrity Compliance.

This article serves as a comprehensive playbook for quality and regulatory professionals to assess risks associated with shared user credentials, allowing for expedient and effective responses to compliance challenges. By the end of this guide, professionals will have actionable strategies to identify symptoms, contain risks, investigate root causes, implement corrective actions, and ensure inspection readiness.

Symptoms/Signals on the Floor or in the Lab

Identifying potential risks associated with shared user credentials is

the first step in management. Symptoms may manifest through a variety of observable behaviors or anomalies, including:

  • Unusual System Activity: Increased logins or transactions from accounts at odd hours or multiple concurrent sessions may indicate shared credentials.
  • Audit Trail Discrepancies: Missing or inconsistent audit trails indicating lapses in user activity can signal data integrity issues.
  • Elevated Error Rates: Increased frequency of data entry errors or lab documentation inaccuracies.
  • Non-compliance Notices: Previous non-conformances, or informal warnings from regulators for data integrity lapses.

Likely Causes (by Category: Materials, Method, Machine, Man, Measurement, Environment)

Understanding likely causes is vital for effective problem-solving. Below are potential categories that contribute to the issues surrounding shared user credentials:

Category Likely Causes
Materials Inadequate training materials leading to confusion about credential usage.
Method Undefined procedures for user account management, especially in transient settings like walkthroughs.
Machine Inadequate database logs due to outdated software not capturing sufficient data.
Man Cultural norms encouraging shared access to maintain productivity, undermining personal accountability.
Measurement Lack of metrics to monitor effective credential management practices.
Environment High-pressure environments where compliance is overlooked for expediency.
Pharma Tip:  Repeat data integrity lapses during internal audit – CAPA effectiveness checks

Immediate Containment Actions (First 60 Minutes)

When symptoms are identified, immediate containment is crucial. Here are actionable steps to execute within the first hour:

  1. Cease Operations: Suspend any ongoing operations that involve shared credentials.
  2. Notify Leadership: Escalate the issue to management for awareness and support.
  3. Account Lockdown: Temporarily lock affected accounts to prevent unauthorized access.
  4. Collect Data: Document all observations, including timestamps and involved personnel.
  5. Establish a Communication Line: Communicate with IT to prepare for a detailed password and access review.

Investigation Workflow (Data to Collect + How to Interpret)

The investigation should be systematic, addressing key variables.

  • User Access Records: Collect and analyze access logs to identify any patterns of abnormal activity.
  • Incident Logs: Review any existing incident or complaint documentation related to data integrity.
  • Interviews: Conduct interviews with involved personnel to gather context and reasons behind shared access.
  • Procedure Review: Examine current user management procedures and training documentation.

Interpret data collectively to identify the extent of the issue and areas requiring urgent corrective measures. Look for trends over time or specific failure points that lead to those incidents.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and When to Use Which

Root cause analysis is essential to identifying underlying factors contributing to shared user credential issues. Consider the following methodologies:

  • 5-Why Analysis: Utilize this technique for straightforward problems. Ask “Why?” up to five times to identify the root cause. Ideal for simpler, direct issues.
  • Fishbone Diagram: Employ this method for more complex problems with multiple contributing factors. This visual aid can help categorize issues into categories such as Man, Method, Machine, etc.
  • Fault Tree Analysis: Use when a systematic breakdown of potential failures is needed. This is beneficial for understanding complex interdependencies.
Pharma Tip:  Data Integrity Findings? ALCOA+ Controls and Remediation Solutions

CAPA Strategy (Correction, Corrective Action, Preventive Action)

The Corrective and Preventive Action (CAPA) system provides a structured approach to resolving issues identified during the investigation:

  • Correction: Ensure immediate rectification of shared credentials; revert to individual user access.
  • Corrective Action: Implement training and a clear policy against shared credentials. Create a governance process for user account management.
  • Preventive Action: Regular audits on credential usage and mandatory refresher training to instill a culture of individual accountability.

Control Strategy & Monitoring (SPC/Trending, Sampling, Alarms, Verification)

To enhance oversight and prevent recurrences, robust control strategies are essential. Here are strategies to consider:

  • Statistical Process Control (SPC): Implement SPC for monitoring user access patterns to catch anomalies quickly.
  • Proactive Sampling: Regularly review a sample of logged activities to check for discrepancies.
  • Alerts and Alarms: Install real-time alerts on unauthorized logins or repeated access attempts using shared credentials.
  • Verification Processes: Regular checks to confirm compliance with revised procedures and prompt corrective actions when lapses are identified.

Validation / Re-qualification / Change Control Impact (When Needed)

Whenever changes are made to access control systems, they must be subject to validation or re-qualification:

  • Validation Plan: Create a validation plan for any changed processes regarding user account management.
  • Re-qualification: Ensure systems involved in data integrity remain compliant through re-qualification.
  • Change Control Procedures: Integrate changes regarding the shared credential policy into the change control system to ensure regulatory compliance.

Inspection Readiness: What Evidence to Show (Records, Logs, Batch Docs, Deviations)

Preparing for inspection entails having the right documentation available. Key elements include:

Related Reads

  • Access Logs: Maintain comprehensive records of user activities and any anomalies noted.
  • Training Records: Document training and retraining on compliance policies related to credentialing.
  • Deviation Reports: All deviations should be tracked and investigated thoroughly to maintain transparency.
  • Corrective Actions Taken: Maintain a record of all CAPAs related to shared credentials for review by inspectors from regulatory bodies like FDA, EMA, or MHRA.

FAQs

What are the main risks of shared user credentials?

The primary risks include accountability loss, potential unauthorized access, breach of data integrity, and increased likelihood of regulatory non-compliance.

Pharma Tip:  Audit trail gaps identified during system validation – 483 risk assessment

How can I enforce individual accountability for login credentials?

Implement strict policies against shared credentials, establish disciplinary actions for non-compliance, and use technology to enforce unique user IDs.

What should I do if I suspect shared credentials are being used?

Immediately contain the situation by suspending access, informing management, and initiating an investigation to uncover the extent of the issue.

How often should user access be audited?

It’s best practice to conduct audits quarterly, or when significant procedural changes occur, to ensure compliance and accountability.

What documentation is needed during an inspection regarding data integrity?

You should be prepared to present access logs, training records, incident reports, and any CAPA documentation pertaining to data integrity.

Are shared credentials allowed in any phase of pharmaceutical operations?

No, shared credentials should be strictly prohibited to maintain compliance with regulatory guidelines and ensure accountability.

What regulatory bodies outline the guidelines for data integrity?

The FDA, EMA, and MHRA all outline strict requirements regarding data integrity under their respective regulations.

How can I ensure my facility is inspection-ready?

Regular training, robust documentation of SOPs, continual audits, and immediate corrective actions for any discrepancies are essential for maintaining inspection readiness.

What is the significance of ALCOA+ in data integrity?

ALCOA+ ensures that data is Attributable, Legible, Contemporaneous, Original, and Accurate, which are crucial traits for ensuring data integrity in pharmaceutical operations.

What are the implications of not addressing shared credential use?

Failure to address this issue can result in regulatory citations, financial penalties, and significant reputational damage to the organization.

When is it necessary to initiate a validation process after incidents involving credentials?

A validation process should be initiated whenever a significant change is made in user management protocols or when incident investigations reveal a gap in processes.

What strategies can be employed to maintain long-term compliance?

Consistent review of SOPs, ongoing training, robust monitoring systems, and immediate corrective actions for non-conformances are essential strategies for sustaining long-term compliance.